Combination vaccines against diarrheal diseases

References

• Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 2012; 380:2055-8; PMID:23245598; http://dx.doi.org/10.1016/S0140-6736(12)62134-5
   PubMed Web of Science ®Google Scholar
• Walker CL, Aryee MJ, Boschi-Pinto C, Black RE. Estimating diarrhea mortality among young children in low and middle income countries. PloS one 2012; 7:e29151; PMID:22235266; http://dx.doi.org/10.1371/journal.pone.0029151
   PubMed Web of Science ®Google Scholar
• UNICEF-WHO. Diarrhea: why children are still dying and what can be done? NY, United Nations Children Fund. 2009.
   Google Scholar
• Wardlaw T, Salama P, Brocklehurst C, Chopra M, Mason E. Diarrhoea: why children are still dying and what can be done. Lancet 2010; 375:870-2; PMID:19833382; http://dx.doi.org/10.1016/S0140-6736(09)61798-0
   PubMedGoogle Scholar
• WHO. Years of life lost due to premature mortality-trends and causes. World Health Statistics 2014 2014:45-9.
   Google Scholar
• Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE, Child Health Epidemiology Reference Group of the World Health Organization and UNICEF. Global causes of diarrheal disease mortality in children. PloS one 2013; 8:e72788; PMID:24023773; http://dx.doi.org/10.1371/journal.pone.0072788
   PubMed Web of Science ®Google Scholar
• Fischer Walker CL, Munos MK, Black RE. Quantifying the indirect effects of key child survival interventions for pneumonia, diarrhoea, and measles. Epidemiol Infect 2013; 141:115-31; PMID:22793874; http://dx.doi.org/10.1017/S0950268812001525
   PubMedGoogle Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-128; PMID:23245604; http://dx.doi.org/10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197-223; PMID:23245608; http://dx.doi.org/10.1016/S0140-6736(12)61689-4
   PubMed Web of Science ®Google Scholar
• Fischer Walker CL, Sack D, Black RE. Etiology of diarrhea in older children, adolescents and adults: a systematic review. PloS Negl Trop Dis 2010; 4:e768; PMID:20689809; http://dx.doi.org/10.1371/journal.pntd.0000768
   PubMed Web of Science ®Google Scholar
• Haeusler GM, Curtis N. Non-typhoidal Salmonella in children: microbiology, epidemiology and treatment. Adv Exp Med Biol 2013; 764:13-26; PMID:23654054; http://dx.doi.org/10.1007/978-1-4614-4726-9_2
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH, van Eijk A, Adegbola RA, Alonso PL, Breiman RF, Faruque AS, et al. The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis 2012; 55 Suppl 4:S232-45; PMID:23169936; http://dx.doi.org/10.1093/cid/cis753
   PubMedGoogle Scholar
• Levine MM, Kotloff KL, Nataro JP, Muhsen K. The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis. Clin Infect Dis 2012; 55 Suppl 4:S215-24; PMID:23169934; http://dx.doi.org/10.1093/cid/cis761
   PubMedGoogle Scholar
• Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209-22; PMID:23680352; http://dx.doi.org/10.1016/S0140-6736(13)60844-2
   PubMed Web of Science ®Google Scholar
• Lindsay B, Ochieng JB, Ikumapayi UN, Toure A, Ahmed D, Li S, Panchalingam S, Levine MM, Kotloff K, Rasko DA, et al. Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries. J Clin Microbiol 2013; 51:1740-6; PMID:23536399; http://dx.doi.org/10.1128/JCM.02713-12
   PubMed Web of Science ®Google Scholar
• Checkley W, Buckley G, Gilman RH, Assis AM, Guerrant RL, Morris SS, Mølbak K, Valentiner-Branth P, Lanata CF, Black RE, et al. Multi-country analysis of the effects of diarrhoea on childhood stunting. IntJ Epidemiol 2008; 37:816-30; PMID:18567626; http://dx.doi.org/10.1093/ije/dyn099
   PubMed Web of Science ®Google Scholar
• Richard SA, Black RE, Gilman RH, Guerrant RL, Kang G, Lanata CF, Mølbak K, Rasmussen ZA, Sack RB, Valentiner-Branth P, et al. Diarrhea in early childhood: short-term association with weight and long-term association with length. AmJ Epidemiol 2013; 178:1129-38; PMID:23966558; http://dx.doi.org/10.1093/aje/kwt094
   PubMed Web of Science ®Google Scholar
• Fischer Walker CL, Lamberti L, Adair L, Guerrant RL, Lescano AG, Martorell R, Pinkerton RC, Black RE. Does childhood diarrhea influence cognition beyond the diarrhea-stunting pathway? PloS One 2012; 7:e47908; PMID:23118906
   PubMed Web of Science ®Google Scholar
• Lamberti LM, Fischer Walker CL, Black RE. Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries. BMC Public Health 2012; 12:276; PMID:22480268; http://dx.doi.org/10.1186/1471-2458-12-276
   PubMed Web of Science ®Google Scholar
• CDC. Foodborne diseases active surveillance network (FoodNet): foodnet surveillance report for 2011. 2012. http://www.cdc.gov/foodnet/PDFs/2011_annual_report_508c.pdf
   Google Scholar
• Caeiro JP, Estrada-Garcia MT, Jiang ZD, Mathewson JJ, Adachi JA, Steffen R, DuPont HL. Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique. The Journal of infectious diseases 1999; 180:2053-5; PMID:10558969; http://dx.doi.org/10.1086/315121
   PubMed Web of Science ®Google Scholar
• Lothigius A, Janzon A, Begum Y, Sjoling A, Qadri F, Svennerholm AM, Bölin I. Enterotoxigenic Escherichia coli is detectable in water samples from an endemic area by real-time PCR. Journal of applied microbiology 2008; 104:1128-36; PMID:17976169; http://dx.doi.org/10.1111/j.1365-2672.2007.03628.x
   PubMedGoogle Scholar
• Harvey K, Esposito DH, Han P, Kozarsky P, Freedman DO, Plier DA, Sotir MJ; Centers for Disease Control and Prevention (CDC). Surveillance for travel-related disease–GeoSentinel Surveillance System, United States, 1997–2011. Morbidity and mortality weekly report Surveillance summaries 2013; 62:1-23; PMID:23863769
   PubMed Web of Science ®Google Scholar
• Putnam SD, Sanders JW, Frenck RW, Monteville M, Riddle MS, Rockabrand DM, Sharp TW, Frankart C, Tribble DR. Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom. Journal of travel medicine 2006; 13:92-9; PMID:16553595; http://dx.doi.org/10.1111/j.1708-8305.2006.00020.x
   PubMedGoogle Scholar
• Porter CK, Choi D, Cash B, Pimentel M, Murray J, May L, Riddle MS. Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. BMC gastroenterology 2013; 13:46; PMID:23510245; http://dx.doi.org/10.1186/1471-230X-13-46
   PubMed Web of Science ®Google Scholar
• Porter CK, Gloor K, Cash BD, Riddle MS. Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment. Digestive diseases and sciences 2011; 56:3262-9; PMID:21643738; http://dx.doi.org/10.1007/s10620-011-1762-3
   PubMedGoogle Scholar
• Porter CK, Thura N, Riddle MS. Quantifying the incidence and burden of postinfectious enteric sequelae. Military medicine 2013; 178:452-69; PMID:23707833; http://dx.doi.org/10.7205/MILMED-D-12-00510
   PubMedGoogle Scholar
• Connor P, Porter CK, Swierczewski B, Riddle MS. Diarrhoea during military deployment: current concepts and future directions. Current opinion in infectious diseases 2012; 25:546-54; PMID:22907281; http://dx.doi.org/10.1097/QCO.0b013e3283582ebc
   PubMedGoogle Scholar
• Connor BA. Traveler's Diarrhea. CDC Health Information for International Travel 2014, ed GW Brunette, Oxford University Press, New York, NY 10016 2014; Chapter 2, under Self Treatable Conditions.
   Google Scholar
• Greenwood Z, Black J, Weld L, O'Brien D, Leder K, Von Sonnenburg F, Pandey P, Schwartz E, Connor BA, Brown G, et al. Gastrointestinal infection among international travelers globally. Journal of travel medicine 2008; 15:221-8; PMID:18666921; http://dx.doi.org/10.1111/j.1708-8305.2008.00203.x
   PubMedGoogle Scholar
• Swaminathan A, Torresi J, Schlagenhauf P, Thursky K, Wilder-Smith A, Connor BA, Schwartz E, Vonsonnenberg F, Keystone J, O'Brien DP, et al. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. The Journal of infection 2009; 59:19-27; PMID:19552961; http://dx.doi.org/10.1016/j.jinf.2009.05.008
   PubMed Web of Science ®Google Scholar
• Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. The American journal of tropical medicine and hygiene 2009; 80:609-14; PMID:19346386
   PubMed Web of Science ®Google Scholar
• Rathaur VK, Pathania M, Jayara A, Yadav N. Clinical study of acute childhood diarrhoea caused by bacterial enteropathogens. Journal of clinical and diagnostic research : JCDR 2014; 8:PC01-5; PMID:24995223
   PubMedGoogle Scholar
• Stark D, Roberts T, Ellis JT, Marriott D, Harkness J. Evaluation of the EasyScreen enteric parasite detection kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples. Diagnostic microbiology and infectious disease 2014; 78:149-52; PMID:24286625; http://dx.doi.org/10.1016/j.diagmicrobio.2013.10.013
   PubMedGoogle Scholar
• Sanchez-Vega JT, Cabrera-Fuentes HA, Romero-Olmedo AJ, Ortiz-Frias JL, Sokolina F, Barreto G. Cyclospora cayetanensis: this emerging protozoan pathogen in Mexico. The American journal of tropical medicine and hygiene 2014; 90:351-3; PMID:24379243; http://dx.doi.org/10.4269/ajtmh.12-0782
   PubMedGoogle Scholar
• Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. The Lancet infectious diseases 2014; 14:725-30; PMID:24981041; http://dx.doi.org/10.1016/S1473-3099(14)70767-4
   PubMed Web of Science ®Google Scholar
• Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, Steffen R, Ericsson CD, DuPont HL. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001; 32:1706-9; PMID:11360211; http://dx.doi.org/10.1086/320756
   PubMed Web of Science ®Google Scholar
• Ruiz J, Marco F, Oliveira I, Vila J, Gascon J. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007; 115:218-24; PMID:17367467; http://dx.doi.org/10.1111/j.1600-0463.2007.apm_567.x
   PubMed Web of Science ®Google Scholar
• Navia MM, Ruiz J, Vila J. Molecular characterization of the integrons in Shigella strains isolated from patients with traveler's diarrhea. Diagnostic microbiology and infectious disease 2004; 48:175-9; PMID:15023426; http://dx.doi.org/10.1016/j.diagmicrobio.2003.10.007
   PubMedGoogle Scholar
• Vila J, Vargas M, Henderson IR, Gascon J, Nataro JP. Enteroaggregative Escherichia coli virulence factors in traveler's diarrhea strains. The Journal of infectious diseases 2000; 182:1780-3; PMID:11069254; http://dx.doi.org/10.1086/317617
   PubMedGoogle Scholar
• Sanchez-Vargas FM, Abu-El-Haija MA, Gomez-Duarte OG. Salmonella infections: an update on epidemiology, management, and prevention. Travel medicine and infectious disease 2011; 9:263-77; PMID:22118951; http://dx.doi.org/10.1016/j.tmaid.2011.11.001
   PubMed Web of Science ®Google Scholar
• Cabrera R, Marco F, Vila J, Ruiz J, Gascon J. Class 1 Integrons in Salmonella Strains causing traveler's diarrhea. Antimicrobial agents and chemotherapy 2006; 50:1612-3; PMID:16569899; http://dx.doi.org/10.1128/AAC.50.4.1612-1613.2006
   PubMedGoogle Scholar
• Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infection and immunity 2007; 75:3961-8; PMID:17548483; http://dx.doi.org/10.1128/IAI.00459-07
   PubMed Web of Science ®Google Scholar
• Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clinical microbiology reviews 2005; 18:465-83; PMID:16020685; http://dx.doi.org/10.1128/CMR.18.3.465-483.2005
   PubMed Web of Science ®Google Scholar
• Das SK, Ahmed S, Ferdous F, Farzana FD, Chisti MJ, Leung DT, Malek MA, Talukder KA, Bardhan PK, Salam MA, et al. Changing emergence of Shigella sero-groups in Bangladesh: observation from four different diarrheal disease hospitals. PloS one 2013; 8:e62029; PMID:23658619; http://dx.doi.org/10.1371/journal.pone.0062029
   PubMedGoogle Scholar
• Connor BA. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41 Suppl 8:S577-86; PMID:16267722; http://dx.doi.org/10.1086/432956
   PubMedGoogle Scholar
• Bardhan PN, Dutta HN, Krishnaswami P. Intradermal Tab Immunization against Enteric Infections. The Journal of hygiene 1963; 61:365-72; PMID:14066593; http://dx.doi.org/10.1017/S0022172400039656
   PubMedGoogle Scholar
• Noble JE, Fielding P. Combined enteric and cholera vaccination by the intradermal route. The Journal of hygiene 1965; 63:345-55; PMID:5212837; http://dx.doi.org/10.1017/S002217240004523X
   PubMedGoogle Scholar
• Barr M, Sayers, MHP, Stamm, WP. Intradermal TABT vaccine for immunization against enteric. Lancet 1959; 1:816-17; PMID:13642909
   PubMedGoogle Scholar
• Kamp M. Mass typhoid fever immunization: Intradermal method. J Ind med Ass 1943; 36:584.
   Google Scholar
• Felix A, Bensted HJ. Proposed standard agglutinating sera for typhoid and paratyphoid A and B fevers. Bulletin of the World Health Organization 1954; 10:919-26; PMID:13199655
   PubMedGoogle Scholar
• Vella W. On vaccines and vaccination: typhoid-paratyphoid fevers. Postgraduate medical journal 1972; 48:98-106; PMID:4622606; http://dx.doi.org/10.1136/pgmj.48.556.98
   PubMedGoogle Scholar
• Hornick RB. Typhoid immunization recommendation of the Immunization Practices Advisory Committee. MMWR-CDC 1990; 39:1-5; PMID:2165557
   PubMedGoogle Scholar
• FDA. http://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm175909.pdf. 2014.
   Google Scholar
• Nasrin D, Wu Y, Blackwelder WC, Farag TH, Saha D, Sow SO, Alonso PL, Breiman RF, Sur D, Faruque AS, et al. Health care seeking for childhood diarrhea in developing countries: evidence from seven sites in Africa and Asia. The American journal of tropical medicine and hygiene 2013; 89:3-12; PMID:23629939; http://dx.doi.org/10.4269/ajtmh.12-0749
   PubMedGoogle Scholar
• Manna B, Nasrin D, Kanungo S, Roy S, Ramamurthy T, Kotloff KL, Levine MM, Sur D. Determinants of health care seeking for diarrheal illness in young children in urban slums of Kolkata, India. The American journal of tropical medicine and hygiene 2013; 89:56-61; PMID:23629936; http://dx.doi.org/10.4269/ajtmh.12-0756
   PubMedGoogle Scholar
• Bohles N, Busch K, Hensel M. Vaccines against human diarrheal pathogens: Current status and perspectives. Human vaccines & immunotherapeutics 2014; 10; PMID:24861668; http://dx.doi.org/10.4161/hv.29241
   PubMedGoogle Scholar
• Modlin JF. Inactivated polio vaccine and global polio eradication. The Lancet infectious diseases 2012; 12:93-4; PMID:22071250; http://dx.doi.org/10.1016/S1473-3099(11)70312-7
   PubMedGoogle Scholar
• Thompson KM, Duintjer Tebbens RJ. National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication. Expert review of vaccines 2014; 13:221-34; PMID:24308581; http://dx.doi.org/10.1586/14760584.2014.864563
   PubMed Web of Science ®Google Scholar
• Thomassen YE, van 't Oever AG, van Oijen MG, Wijffels RH, van der Pol LA, Bakker WA. Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals. PloS one 2013; 8:e83374; PMID:24349497; http://dx.doi.org/10.1371/journal.pone.0083374
   PubMed Web of Science ®Google Scholar
• Jensen H, Benn CS, Aaby P. DTP in low income countries: improved child survival or survival bias? Bmj 2005; 330:845-6; PMID:15817558; http://dx.doi.org/10.1136/bmj.330.7495.845-a
   PubMed Web of Science ®Google Scholar
• Robbins JB, Schneerson R, Keith JM, Shiloach J, Miller M, Trollors B. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. Vaccine 2007; 25:2811-6; PMID:17291636; http://dx.doi.org/10.1016/j.vaccine.2006.12.013
   PubMed Web of Science ®Google Scholar
• Corbel MJ, Das RG, Lei D, Xing DK, Horiuchi Y, Dobbelaer R, WHO Working Group. WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland. Vaccine 2008; 26:1913-21; PMID:18336960; http://dx.doi.org/10.1016/j.vaccine.2008.02.013
   PubMedGoogle Scholar
• He H, Chen E, Chen H, Wang Z, Li Q, Yan R, Guo J, Zhou Y, Pan J, Xie S. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children. Vaccine 2014; 32:4001-5; PMID:24837773; http://dx.doi.org/10.1016/j.vaccine.2014.04.044
   PubMedGoogle Scholar
• Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Vaccine 2014; 32:1147-52; PMID:24440207; http://dx.doi.org/10.1016/j.vaccine.2014.01.002
   PubMedGoogle Scholar
• Stokes J, Jr., Weibel RE, Villarejos VM, Arguedas JA, Buynak EB, Hilleman MR. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies. JAMA : the journal of the American Medical Association 1971; 218:57-61; http://dx.doi.org/10.1001/jama.1971.03190140033006
   PubMed Web of Science ®Google Scholar
• Howe BJ. Diphtheria-tetanus-acellular pertussis (DTaP) vaccine. JAMA : the journal of the American Medical Association 1996; 276:1803-4; PMID:8946898; http://dx.doi.org/10.1001/jama.1996.03540220027023
   PubMedGoogle Scholar
• MMWR. Food and Drug Administration approval of use of diptheria and tetanus toxoids and acellualr pertussis vaccine 1991; 40:881-2.
   Google Scholar
• Fine A. Diptheria, tetanus and acellular pertussis vaccine (DTaP): a case study. Institute of Medicine, 500 5th st, NW, Washington DC. 2003.
   Google Scholar
• Miller JJ, Jr., Ryan ML. Immunization with combined diptheria and tetanus toxoids (aluminum hydroxide adsorbed) containing H. pertussis vaccine. The duration of serologic immunity. Pediatrics 1948; 1:8-22; PMID:18905779
   PubMedGoogle Scholar
• Vesikari T, Silfverdal SA, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age. Clin Vaccin Immunol 2013; 20:1647-53; PMID:23966556; http://dx.doi.org/10.1128/CVI.00414-13
   PubMedGoogle Scholar
• Sheridan SL, Ware RS, Grimwood K, Lambert SB. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. ClinIinfect Dis 2012; 55:1434-5; author reply 5-6; PMID:22871826; http://dx.doi.org/10.1093/cid/cis672
   PubMedGoogle Scholar
• Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA : the journal of the American Medical Association 2012; 308:454-6; PMID:22851107
   PubMedGoogle Scholar
• Capeding MR, Cadorna-Carlos J, Book-Montellano M, Ortiz E. Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial. Bull World Health Org 2008; 86:443-51; PMID:18568273
   PubMedGoogle Scholar
• Aristegui J, Dal-Re R, Diez-Delgado J, Mares J, Casanovas JM, Garcia-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, et al. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age. Vaccine 2003; 21:3593-600; PMID:12922087; http://dx.doi.org/10.1016/S0264-410X(03)00420-1
   PubMed Web of Science ®Google Scholar
• Kanra G, Silier T, Yurdakok K, Yavuz T, Baskan S, Ulukol B, Ceyhan M, Ozmert E, Türkay F, Pehlivan T. Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life. Vaccine 1999; 18:947-54; PMID:10580209; http://dx.doi.org/10.1016/S0264-410X(99)00331-X
   PubMedGoogle Scholar
• Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granstrom M, Blondeau C, Hoffenbach A. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. Pediatr Infect Dis J 1998; 17:1026-33; PMID:9849987; http://dx.doi.org/10.1097/00006454-199811000-00013
   PubMed Web of Science ®Google Scholar
• Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999; 354:2063-8; PMID:10636384; http://dx.doi.org/10.1016/S0140-6736(99)04377-9
   PubMed Web of Science ®Google Scholar
• Guerra FA, Blatter MM, Greenberg DP, Pichichero M, Noriega FR, Pentacel Study G. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Pediatrics 2009; 123:301-12; PMID:19117896; http://dx.doi.org/10.1542/peds.2007-3317
   PubMed Web of Science ®Google Scholar
• Southern J, Crowley-Luke A, Borrow R, Andrews N, Miller E. Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine. Vaccine 2006; 24:215-9; PMID:16112255; http://dx.doi.org/10.1016/j.vaccine.2005.07.060
   PubMed Web of Science ®Google Scholar
• Rennels MB, Englund JA, Bernstein DI, Losonsky GA, Anderson EL, Pichichero ME, et al. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. Pediatr Infecti Dis J 2000; 19:417-23; PMID:10819337; http://dx.doi.org/10.1097/00006454-200005000-00006
   PubMed Web of Science ®Google Scholar
• Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Munoz FM, Wolff MC. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Vaccine 2006; 24:1776-85; PMID:16303216; http://dx.doi.org/10.1016/j.vaccine.2005.10.023
   PubMedGoogle Scholar
• Dhillon S. DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination. Drugs 2010; 70:1021-58; PMID:20481658; http://dx.doi.org/10.2165/11204830-000000000-00000
   PubMed Web of Science ®Google Scholar
• Johns TL, Hutter GE. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). Ann Pharmacother 2010; 44:515-23; PMID:20197476; http://dx.doi.org/10.1345/aph.1M468
   PubMedGoogle Scholar
• Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane database of Syst Rev 2012; 4:CD005530; PMID:22513932
   PubMedGoogle Scholar
• Marshall GS, Marchant CD, Blatter M, Friedland LR, Aris E, Miller JM. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States. Human Vaccin 2011; 7:258-64; PMID:21307655; http://dx.doi.org/10.4161/hv.7.2.14170
   PubMed Web of Science ®Google Scholar
• Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gomez-Campdera JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, et al. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 2006; 25:713-20; PMID:16874171; http://dx.doi.org/10.1097/01.inf.0000227725.61495.c4
   PubMed Web of Science ®Google Scholar
• Tejedor JC, Omenaca F, Garcia-Sicilia J, Esporrin C, Molina V, Mares J, Muro M, Sanjuan P, Méndez M, Teixidor R, et al. Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HiB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HiB booster at 18 months of age. Pediatr Infect Dis J 2006; 25:943-5; PMID:17006294; http://dx.doi.org/10.1097/01.inf.0000237917.60734.05
   PubMed Web of Science ®Google Scholar
• Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine 2006; 24:4727-36; PMID:16616973; http://dx.doi.org/10.1016/j.vaccine.2006.03.032
   PubMed Web of Science ®Google Scholar
• Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. The Pediatr Infect Dis J 2009; 28:S109-18; PMID:19325447; http://dx.doi.org/10.1097/INF.0b013e318199f62d
   PubMed Web of Science ®Google Scholar
• Gimenez-Sanchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Diez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, et al. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine. Vaccine 2011; 29:6042-8; PMID:21704105; http://dx.doi.org/10.1016/j.vaccine.2011.06.026
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccin Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10
   PubMed Web of Science ®Google Scholar
• White C, Halperin SA, Scheifele DW. Pediatric combined formulation DTaP-IPV/Hib vaccine. Expert Rev Vaccines 2009; 8:831-40; PMID:19538110; http://dx.doi.org/10.1586/erv.09.59
   PubMed Web of Science ®Google Scholar
• Skibinski DA, Baudner BC, Singh M, O'Hagan DT. Combination vaccines. J Global Infect Dis 2011; 3:63-72; PMID:21572611; http://dx.doi.org/10.4103/0974-777X.77298
   PubMedGoogle Scholar
• Marathe SA, Lahiri A, Negi VD, Chakravortty D. Typhoid fever & vaccine development: a partially answered question. Indian J Med Res 2012; 135:161-9; PMID:22446857
   PubMed Web of Science ®Google Scholar
• Bhuiyan TR, Choudhury FK, Khanam F, Saha A, Sayeed MA, Salma U, Lundgren A, Sack DA, Svennerholm AM, Qadri F. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Vaccine 2014; 32:1055-60; PMID:24440210; http://dx.doi.org/10.1016/j.vaccine.2014.01.001
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, et al. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis 2014; 14:119-29; PMID:24290843; http://dx.doi.org/10.1016/S1473-3099(13)70241-X
   PubMed Web of Science ®Google Scholar
• Simon R, Tennant SM, Galen JE, Levine MM. Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge. Vaccine 2011; 29:5094-106; PMID:21616112; http://dx.doi.org/10.1016/j.vaccine.2011.05.022
   PubMedGoogle Scholar
• Strugnell RA, Scott TA, Wang N, Yang C, Peres N, Bedoui S, Kupz A. Salmonella vaccines: lessons from the mouse model or bad teaching? Curr Opin Microbiol 2014; 17:99-105; PMID:24440968; http://dx.doi.org/10.1016/j.mib.2013.12.004
   PubMedGoogle Scholar
• Wahid R, Zafar SJ, McArthur MA, Pasetti MF, Levine MM, Sztein MB. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Clin Vaccine Immunol 2014; 21:427-34; PMID:24429069; http://dx.doi.org/10.1128/CVI.00786-13
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD. Rotavirus vaccines–balancing intussusception risks and health benefits. N Engl J Med 2014; 370:568-70; PMID:24422677; http://dx.doi.org/10.1056/NEJMe1315836
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Systemat Rev 2012; 11:CD008521; PMID:23152260
   PubMed Web of Science ®Google Scholar
• Dennehy PH, Bertrand HR, Silas PE, Damaso S, Friedland LR, Abu-Elyazeed R. Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States. Pediatrics 2008; 122:e1062-6; PMID:18977955; http://dx.doi.org/10.1542/peds.2008-1059
   PubMed Web of Science ®Google Scholar
• Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Parashar UD. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007-2011). Pediatrics 2014; 134:15-23; PMID:24913793;http://dx.doi.org/10.1542/peds.2013-3849
   PubMed Web of Science ®Google Scholar
• Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006–2012. Expert Rev Vaccines 2014; 13:365-76; PMID:24392657; http://dx.doi.org/10.1586/14760584.2014.877846
   PubMed Web of Science ®Google Scholar
• Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD. Rotavirus vaccines: Current status and future considerations. Hum Vaccines Immunother 2014; 10:1436-48; PMID:24755452
   PubMed Web of Science ®Google Scholar
• Ryan ET, Calderwood SB, Qadri F. Live attenuated oral cholera vaccines. Expert Rev Vaccines 2006; 5:483-94; PMID:16989629; http://dx.doi.org/10.1586/14760584.5.4.483
   PubMed Web of Science ®Google Scholar
• Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 2011; 133:188-96; PMID:21415493
   PubMed Web of Science ®Google Scholar
• Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine 2011; 29:8285-92; PMID:21907255; http://dx.doi.org/10.1016/j.vaccine.2011.08.108
   PubMed Web of Science ®Google Scholar
• Chen WH, Greenberg RN, Pasetti MF, Livio S, Lock M, Gurwith M, Levine MM. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks. Clin Vaccine Immunol 2014; 21:66-73; PMID:24173028; http://dx.doi.org/10.1128/CVI.00601-13
   PubMed Web of Science ®Google Scholar
• Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, Antonio M, Hossain A, Mandomando I, Ochieng JB, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis 2014; 59:933-41; PMID:24958238; http://dx.doi.org/10.1093/cid/ciu468
   PubMed Web of Science ®Google Scholar
• Martinez-Becerra FJ, Scobey M, Harrison K, Choudhari SP, Quick AM, Joshi SB, Middaugh CR, Picking WL. Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. Vaccine 2013; 31:2667-72; PMID:23602665; http://dx.doi.org/10.1016/j.vaccine.2013.04.012
   PubMedGoogle Scholar
• Savarino SJ, O'Dowd A, Poole S, Maciel M, Rollenhagen J, McVeigh A, et al. Adavancement of an adhesin-based ETEC vaccine into clinical evaluation. 6th International Conferenceon Vaccines for Enteric Diseases (VED) 2011 2011; Cannes, france:Sep 14-6.
   Google Scholar
• Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, Bentzel DE, Applebee L, Guerry P. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect Immun 2009; 77:1128-36; PMID:19114545; http://dx.doi.org/10.1128/IAI.01056-08
   PubMed Web of Science ®Google Scholar
• Maue AC, Mohawk KL, Giles DK, Poly F, Ewing CP, Jiao Y, Lee G, Ma Z, Monteiro MA, Hill CL, et al. The polysaccharide capsule of Campylobacter jejuni modulates the host immune response. Infect Immun 2013; 81:665-72; PMID:23250948; http://dx.doi.org/10.1128/IAI.01008-12
   PubMed Web of Science ®Google Scholar
• Scott DA. Vaccines against Campylobacter jejuni. J Infect Dis 1997; 176 Suppl 2:S183-8; PMID:9396708; http://dx.doi.org/10.1086/513791
   PubMedGoogle Scholar
• Kaminski RW, Wu M, Turbyfill KR, Clarkson K, Tai B, Bourgeois AL, Van De Verg LL, Walker RI, Oaks EV. Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. Clin Vaccine Immunol 2014; 21:366-82; PMID:24403527; http://dx.doi.org/10.1128/CVI.00683-13
   PubMedGoogle Scholar
• Venkatesan MM, Ranallo RT. Live-attenuated Shigella vaccines. Expert Rev Vaccines 2006; 5:669-86; PMID:17181440; http://dx.doi.org/10.1586/14760584.5.5.669
   PubMed Web of Science ®Google Scholar
• Riddle MS, Kaminski RW, Williams C, Porter C, Baqar S, Kordis A, Gilliland T, Lapa J, Coughlin M, Soltis C, et al. Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine 2011; 29:7009-19; PMID:21787825; http://dx.doi.org/10.1016/j.vaccine.2011.07.033
   PubMed Web of Science ®Google Scholar
• Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, Chakraborty S, Buchwaldt C, Darsley MJ. A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol 2011; 18:2118-27; PMID:21994354; http://dx.doi.org/10.1128/CVI.05342-11
   PubMedGoogle Scholar
• Passwell JH, Ashkenzi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, et al. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. Vaccine 2010; 28:2231-5; PMID:20056180; http://dx.doi.org/10.1016/j.vaccine.2009.12.050
   PubMed Web of Science ®Google Scholar
• Darsley MJ, Chakraborty S, DeNearing B, Sack DA, Feller A, Buchwaldt C, Bourgeois AL, Walker R, Harro CD. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol 2012; 19:1921-31; PMID:23035175; http://dx.doi.org/10.1128/CVI.00364-12
   PubMed Web of Science ®Google Scholar
• Riddle MS, Savarino SJ. Moving beyond a heat-labile enterotoxin-based vaccine against enterotoxigenic Escherichia coli. Lancet Infecti Dis 2014; 14:174-5; PMID:24291167; http://dx.doi.org/10.1016/S1473-3099(13)70355-4
   PubMedGoogle Scholar
• Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, et al. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis 2014; 14:197-204; PMID:24291168; http://dx.doi.org/10.1016/S1473-3099(13)70297-4
   PubMed Web of Science ®Google Scholar
• Kaminski RW, Oaks EV. Inactivated and subunit vaccines to prevent shigellosis. Expert Rev Vaccines 2009; 8:1693-704; PMID:19943764; http://dx.doi.org/10.1586/erv.09.127
   PubMed Web of Science ®Google Scholar
• Turbyfill KR, Kaminski RW, Oaks EV. Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. Vaccine 2008; 26:1353-64; PMID:18276045; http://dx.doi.org/10.1016/j.vaccine.2007.12.040
   PubMed Web of Science ®Google Scholar
• Ruan X, Robertson DC, Nataro JP, Clements JD, Zhang W, Group STTVC. Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies. Infect Immun 2014; 82:1823-32; PMID:24549325; http://dx.doi.org/10.1128/IAI.01394-13
   PubMed Web of Science ®Google Scholar
• Roy K, Hamilton DJ, Fleckenstein JM. Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli. Clinical and vaccine immunology : CVI 2012; 19:1603-8; PMID:22875600
   PubMedGoogle Scholar
• Tacket CO. Plant-based oral vaccines: results of human trials. Curr Topics Microbiol Immunol 2009; 332:103-17; PMID:19401823
   PubMed Web of Science ®Google Scholar
• Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. Int J Med Microbiol 2013; 303:105-13; PMID:23474241; http://dx.doi.org/10.1016/j.ijmm.2013.01.001
   PubMed Web of Science ®Google Scholar
• Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Systemat Rev 2013; 7:CD009029; PMID:23828581
   PubMed Web of Science ®Google Scholar
• Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thony-Meyer L. Production of glycoprotein vaccines in Escherichia coli. Microbial Cell Factories 2010; 9:61; PMID:20701771; http://dx.doi.org/10.1186/1475-2859-9-61
   PubMed Web of Science ®Google Scholar
• Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Belot F, Cohen D, Sansonetti PJ, Mulard LA. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J Immunol 2009; 182:2241-7; PMID:19201878; http://dx.doi.org/10.4049/jimmunol.0803141
   PubMed Web of Science ®Google Scholar
• Ranallo RT, Fonseka S, Boren TL, Bedford LA, Kaminski RW, Thakkar S, Venkatesan MM. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates. Vaccine 2012; 30:5159-71; PMID:22658966; http://dx.doi.org/10.1016/j.vaccine.2012.05.003
   PubMedGoogle Scholar
• Zhang W, Sack DA. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans. Expert Rrev Vaccines 2012; 11:677-94; PMID:22873126; http://dx.doi.org/10.1586/erv.12.37
   PubMed Web of Science ®Google Scholar
• Tokuhara D, Yuki Y, Nochi T, Kodama T, Mejima M, Kurokawa S, Takahashi Y, Nanno M, Nakanishi U, Takaiwa F, et al. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci U S A 2010; 107:8794-9; PMID:20421480; http://dx.doi.org/10.1073/pnas.0914121107
   PubMed Web of Science ®Google Scholar
• Camacho AI, Souza-Reboucas J, Irache JM, Gamazo C. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies. Methods 2013; 60:264-8; PMID:23046911; http://dx.doi.org/10.1016/j.ymeth.2012.09.008
   PubMedGoogle Scholar
• Barnoy S, Baqar S, Kaminski RW, Collins T, Nemelka K, Hale TL, Ranallo RT, Venkatesan MM. Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. Vaccine 2011; 29:6371-8; PMID:21596086; http://dx.doi.org/10.1016/j.vaccine.2011.04.115
   PubMed Web of Science ®Google Scholar
• Martinez-Becerra FJ, Chen X, Dickenson NE, Choudhari SP, Harrison K, Clements JD, Picking WD, Van De Verg LL, Walker RI, Picking WL. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine. Infect Immun 2013; 81:4470-7; PMID:24060976; http://dx.doi.org/10.1128/IAI.00859-13
   PubMedGoogle Scholar
• Barry EM, Pasetti MF, Sztein MB, Fasano A, Kotloff KL, Levine MM. Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol 2013; 10:245-55; PMID:23419287; http://dx.doi.org/10.1038/nrgastro.2013.12
   PubMedGoogle Scholar
• Lundgren A, Leach S, Tobias J, Carlin N, Gustafsson B, Jertborn M, Bourgeois L, Walker R, Holmgren J, Svennerholm AM. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine 2013; 31:1163-70; PMID:23306362; http://dx.doi.org/10.1016/j.vaccine.2012.12.063
   PubMed Web of Science ®Google Scholar
• Ashkenazi S, Cohen D. An update on vaccines against Shigella. Therap Adv Vaccines 2013; 1:113-23; PMID:24757519; http://dx.doi.org/10.1177/2051013613500428
   PubMedGoogle Scholar
• de la Cabada Bauche J, Dupont HL. New Developments in Traveler's Diarrhea. Gastroenterology & hepatology 2011; 7:88-95; PMID:21475415
   PubMedGoogle Scholar
• Riddle MS, Rockabrand DM, Schlett C, Monteville MR, Frenck RW, Romine M, Ahmed SF, Sanders JW. A prospective study of acute diarrhea in a cohort of United States military personnel on deployment to the Multinational Force and Observers, Sinai, Egypt. Am J Trop Med Hyg 2011; 84:59-64; PMID:21212203; http://dx.doi.org/10.4269/ajtmh.2011.10-0093
   PubMedGoogle Scholar
• Link W. Diarrhoeal Diseases (Updated February 2009) page. World Health Organization website. Available at: www.who.int/topics/diarrhoea/en/
   Google Scholar
• Farthing MJ. Tropical Malabsorption Semin Gastrointest Dis 2002; 13:221-31; PMID:12465593
   PubMedGoogle Scholar
• Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine 2013; 31:2457-64; PMID:23541621; http://dx.doi.org/10.1016/j.vaccine.2013.03.027
   PubMed Web of Science ®Google Scholar
• Van de Verg L, Venkatesan, M. A Shigella vaccine against prevalent serotypes-editorial commentary. Clin Infec Dis 2014; 59:942-3.
   PubMed Web of Science ®Google Scholar
• Siegrist CA. Neonatal and early life vaccinology. Vaccine 2001; 19:3331-46; PMID:11348697; http://dx.doi.org/10.1016/S0264-410X(01)00028-7
   PubMed Web of Science ®Google Scholar
• Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, Gellin BG, Landry S. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics 2002; 109:124-9; PMID:11773551; http://dx.doi.org/10.1542/peds.109.1.124
   PubMed Web of Science ®Google Scholar
• Dhillon S, Curran MP. Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra). Paediatric drugs 2008; 10:337-47; PMID:18754700; http://dx.doi.org/10.2165/00148581-200810050-00007
   PubMedGoogle Scholar
• Cha SH, Shin SH, Lee TJ, Kim CH, Povey M, Kim HM, Nicholson O. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children. Clin Exp Vaccine Res 2014; 3:91-9; PMID:24427766; http://dx.doi.org/10.7774/cevr.2014.3.1.91
   PubMedGoogle Scholar
• O'Leary ST, Suh CA, Marin M, Vaccine Policy Collaborative I. Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think? Vaccine 2012; 30:6731-3; PMID:22975026; http://dx.doi.org/10.1016/j.vaccine.2012.08.075
   PubMed Web of Science ®Google Scholar
• Valigurova A, Jirku M, Koudela B, Gelnar M, Modry D, Slapeta J. Cryptosporidia: epicellular parasites embraced by the host cell membrane. Inter J Parasitol 2008; 38:913-22; PMID:18158154; http://dx.doi.org/10.1016/j.ijpara.2007.11.003
   PubMedGoogle Scholar
• Maclennan CA, Martin LB, Micoli F. Vaccines against invasive Salmonella disease: Current status and future directions. Hum Vaccin Immunother 2014; 10; PMID:24804797; http://dx.doi.org/10.4161/hv.29054
   PubMedGoogle Scholar
• Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, Kotloff KL, Levine MM, Sow S, Tamboura B, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis 2012; 205:431-44; PMID:22184729; http://dx.doi.org/10.1093/infdis/jir757
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, et al. A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate-Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults. J Infectious Dis. 2014; 210:1763-71.
   Web of Science ®Google Scholar
• Mawas F, Dickinson R, Douglas-Bardsley A, Xing DK, Sesardic D, Corbel MJ. Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model. Vaccine 2006;24:3505-12; PMID:16524648; http://dx.doi.org/10.1016/j.vaccine.2006.02.021
   PubMed Web of Science ®Google Scholar
• Brito LA1 MP, O'Hagan DT. Vaccine adjuvant formulations: a pharmaceutical perspective. Semin Immunol 2013; 25:130-45; PMID:23850011; http://dx.doi.org/10.1016/j.smim.2013.05.007
   PubMedGoogle Scholar
• Baldwin SL, Bertholet S, Reese VA, Ching LK, Reed SG, Coler RN. The importance of adjuvant formulation in the development of a tuberculosis vaccine. J Immunol 2012; 188:2189-97; PMID:22291184; http://dx.doi.org/10.4049/jimmunol.1102696
   PubMed Web of Science ®Google Scholar
• O'Hagan DT, Ott G, Nest GV, Rappuoli R, Giudice G. The history of MF59(®) adjuvant: a phoenix that arose from the ashes. Expert Rev Vaccines 2013; 12:13-30; PMID:23256736; http://dx.doi.org/10.1586/erv.12.140
   PubMed Web of Science ®Google Scholar
• FDA. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172495.htm. 2014.
   Google Scholar
• Di Fabio JL, de Quarles C. Considerations for combination vaccine development and use in the developing world. Clin Infect Dis 2001; 33 Suppl 4:S340-5; PMID:11709770; http://dx.doi.org/10.1086/322571
   PubMedGoogle Scholar